Molecular mechanisms of disease onset in TDP-43 proteinopathies

To investigate if the activation of a immune response pathway, caused by C9orf72 mutation and TDP-43 clumps, is characteristic of pre-symptomatic phase of MND.

28th Nov 2019 
Neuroscience dept portraits 
New Hunts House
KCL, Guys Campus
Frank Hirth

PhD Student: TBC

Principal Investigator: Dr Frank Hirth

Lead Institution: King's College London

MND Association Funding: £104,726

Funding dates: October 2022 - September 2025

About the project

One of the key features in almost all cases of MND, including the most common genetic form related to changes to the C9orf72 gene, is the accumulation of a protein called TDP-43 in the nerve cells of the brain and the spinal cord. Recent research investigating the early changes caused by TDP-43 and C9orf72 found that the activation of an immune response pathway is harmful. This studentship aims to test the hypothesis that this pathway is a characteristic of the pre-symptomatic (has the disease but is not showing any symptoms) phase of MND which then leads to the onset and progression of the disease. Further understanding of mechanisms underlying the early events that affect TDP-43 will help develop new strategies for targeted and lasting treatment of MND.

What does this mean for people living with MND?

As MND is such a complex disease, investigating the early events will help further the understanding of the mechanisms of the disease. This will then help to develop new strategies for targeted treatment of MND.


Want to find out more about this project and researchers? Check out the resources below:


Frank Hirth Archives

Project code: 904-792

For further information and support contact our MND Connect helpline

mndconnect 0808 802 6262